@article{IR,
      author = {Dimagiba, Yvonne T. and Tripathy, Sudeshna and Ellery,  Stacey J. and Snow, Rod J. and Walker, David W. and  Sherman, Larry S. and Kelleher, Meredith A.},
      url = {http://digitalcollections.ohsu.edu/record/9529},
      title = {Maternal and perinatal outcomes of maternal creatine  supplementation as a therapy for neonatal encephalopathy},
      publisher = {Oregon Health and Science University},
      abstract = {Hypoxic ischemic encephalopathy (HIE) occurs in ~4 per  1000 live term births. Infants that receive current  treatments may still develop adverse neurologic outcomes.  Maternal gestational creatine supplementation has been  proposed as a potential prophylactic neuroprotective  therapy, with evidence of reduction in perinatal brain  injury in rodent and sheep studies. The current study aims  to characterize aspects of creatine synthesis, metabolism,  and transport in gestational and neonatal tissues following  maternal oral creatine supplementation.},
      number = {IR},
      doi = {https://doi.org/10.6083/hq37vp30d},
      recid = {9529},
      address = {2022},
}